There are 198 entries in pubmed of which 14 during 2004
so far. Relevant recent reviews include:
Middleton, E., Kandaswami, C. and Theoharides, T.C. The effects
of plant flavonoids on mammalian cells: implications for inflammation,
heart disease and cancer. Pharmacol. Rev. 52:673-751, 2000.
Theoharides, T.C. and Cochrane, D. Critical role of mast cells
in neuroinflammatory diseases and the effect of acute stress. J.
Neuroinmmunol. 146:1-12, 2004
Theoharides, T.C. and Conti, P. Mast cells: the
Jekyll and Hyde of tumor growth. Trends Immunol. 25:235-241,2004
Theoharides TC, Bielory L. Mast cells and
mast cell mediators as targets of dietary supplements. Ann
Allergy Asthma Immunol 93 (2 Suppl 1):S24-34, 2004.
Theoharides, T.C., Panic Disorder Interstitial Cystitis and Mast
cells. J. Clin. Psychopharmacol. 124:361-364, 2004.
Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Duraisamy K,
Conti P. Mast cells as targets of corticotropin-releasing factor
and related peptides. Trends Pharmacol. Sciences,
25:563-568, 2004.
Kempuraj D, Papadopoulou N, Lytinas M, Huang M, Kandere-Grzybowska
K, Madhappan B, Boucher W, Christodoulou S, Athanassiou A. Theoharides
TC . Corticotropin-releasing hormone (CRH) and its structurally
related urocortin (Ucn) are synthesized and secreted by human mast
cells. Endocrinology 145:43-48, 2004.
Green M., Filippou A, Sant GR, Theoharides TC . Expression of intercellular
adhesion molecules in the bladder of interstitial cystitis patients. Urology 63:688-693,
2004.
Kempuraj D., Papadopoulou N, Stanford J, Christodoulou S, Madhappan
B, Sant GR, Theoharides, T.C . Increased numbers of activated mast
cells in endometriosis sites positive for corticotropin-releasing
hormone. Am J Reprod Immunol 52:267-275,
2004.
Theoharides TC , Sant GR. Immunomodulators for the treatment of
interstitial cystitis . Urology , in
press.
Theoharides TC , Weinkauf C, Conti P. Brain cytokines and neuropsychiatric
disorders. J Clin Psychopharmacol ,
in press.
|
